FR2997014B1 - Composition sterile dermo-injectable - Google Patents

Composition sterile dermo-injectable

Info

Publication number: FR2997014B1
Authority: FR; France
Prior art keywords: dermo; injectable sterile; sterile composition; injectable; composition
Prior art date: 2012-10-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR1260146A

Other languages

English (en)

Other versions

FR2997014A1 (fr

Inventor

Francois Bourdon

Stephane Meunier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Teoxane SA

Original Assignee

Teoxane SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-24

Filing date

2012-10-24

Publication date

2015-03-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47754646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2997014(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-10-24 Application filed by Teoxane SA filed Critical Teoxane SA

2012-10-24 Priority to FR1260146A priority Critical patent/FR2997014B1/fr

2013-10-24 Priority to ES13820892T priority patent/ES2735017T5/es

2013-10-24 Priority to JP2015538611A priority patent/JP6521862B2/ja

2013-10-24 Priority to PT13820892T priority patent/PT2912074T/pt

2013-10-24 Priority to PL13820892T priority patent/PL2912074T5/pl

2013-10-24 Priority to AU2013336274A priority patent/AU2013336274B2/en

2013-10-24 Priority to CA2888616A priority patent/CA2888616C/fr

2013-10-24 Priority to RS20190862A priority patent/RS59079B1/sr

2013-10-24 Priority to RU2015118969A priority patent/RU2653729C2/ru

2013-10-24 Priority to KR1020157013662A priority patent/KR102178252B1/ko

2013-10-24 Priority to BR112015009162-8A priority patent/BR112015009162B1/pt

2013-10-24 Priority to SI201331513T priority patent/SI2912074T1/sl

2013-10-24 Priority to EP13820892.1A priority patent/EP2912074B2/fr

2013-10-24 Priority to TR2019/11149T priority patent/TR201911149T4/tr

2013-10-24 Priority to PCT/IB2013/059607 priority patent/WO2014064632A1/fr

2013-10-24 Priority to HUE13820892 priority patent/HUE044362T2/hu

2013-10-24 Priority to DK13820892.1T priority patent/DK2912074T4/da

2013-10-24 Priority to US14/437,917 priority patent/US9907739B2/en

2014-04-25 Publication of FR2997014A1 publication Critical patent/FR2997014A1/fr

2015-03-20 Publication of FR2997014B1 publication Critical patent/FR2997014B1/fr

2015-03-20 Application granted granted Critical

2018-01-18 Priority to US15/874,144 priority patent/US10307362B2/en

2019-07-01 Priority to HRP20191196TT priority patent/HRP20191196T1/hr

Status Active legal-status Critical Current

2032-10-24 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dispersion Chemistry (AREA)
Gerontology & Geriatric Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Compositions Of Macromolecular Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

FR1260146A 2012-10-24 2012-10-24 Composition sterile dermo-injectable Active FR2997014B1 (fr)

Priority Applications (20)

Application Number	Priority Date	Filing Date	Title
FR1260146A FR2997014B1 (fr)	2012-10-24	2012-10-24	Composition sterile dermo-injectable
BR112015009162-8A BR112015009162B1 (pt)	2012-10-24	2013-10-24	Gel de ácido hialurônico reticulado, processo para preparar um gel de ácido hialurônico reticulado, composições dermatológicas, kit e uso de um gel de ácido hialurônico reticulado
EP13820892.1A EP2912074B2 (fr)	2012-10-24	2013-10-24	Composition stérile dermo-injectable
PT13820892T PT2912074T (pt)	2012-10-24	2013-10-24	Composição estéril injetável dérmica
PL13820892T PL2912074T5 (pl)	2012-10-24	2013-10-24	Sterylna kompozycja do wstrzykiwania przez skórę
AU2013336274A AU2013336274B2 (en)	2012-10-24	2013-10-24	Dermal injectable sterile composition
CA2888616A CA2888616C (fr)	2012-10-24	2013-10-24	Composition sterile dermo-injectable
RS20190862A RS59079B1 (sr)	2012-10-24	2013-10-24	Dermalni injekcioni sterilni sastav
RU2015118969A RU2653729C2 (ru)	2012-10-24	2013-10-24	Дермальная инъецируемая стерильная композиция
KR1020157013662A KR102178252B1 (ko)	2012-10-24	2013-10-24	피부 주사가능한 멸균 조성물
ES13820892T ES2735017T5 (es)	2012-10-24	2013-10-24	Composición dérmica inyectable estéril
SI201331513T SI2912074T1 (sl)	2012-10-24	2013-10-24	Dermalni sterilni sestavek za injiciranje
JP2015538611A JP6521862B2 (ja)	2012-10-24	2013-10-24	皮膚用の注入可能な滅菌組成物
TR2019/11149T TR201911149T4 (tr)	2012-10-24	2013-10-24	Dermal enjekte edilebilir steril bileşim.
PCT/IB2013/059607 WO2014064632A1 (fr)	2012-10-24	2013-10-24	Composition stérile dermo-injectable
HUE13820892 HUE044362T2 (hu)	2012-10-24	2013-10-24	Dermálisan injekciózható steril készítmény
DK13820892.1T DK2912074T4 (da)	2012-10-24	2013-10-24	Dermal injicerbar steril sammensætning
US14/437,917 US9907739B2 (en)	2012-10-24	2013-10-24	Dermal injectable sterile composition
US15/874,144 US10307362B2 (en)	2012-10-24	2018-01-18	Dermal injectable sterile composition
HRP20191196TT HRP20191196T1 (hr)	2012-10-24	2019-07-01	Dermalni injektivni sterilni pripravak

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1260146A FR2997014B1 (fr)	2012-10-24	2012-10-24	Composition sterile dermo-injectable

Publications (2)

Publication Number	Publication Date
FR2997014A1 FR2997014A1 (fr)	2014-04-25
FR2997014B1 true FR2997014B1 (fr)	2015-03-20

Family

ID=47754646

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR1260146A Active FR2997014B1 (fr)	2012-10-24	2012-10-24	Composition sterile dermo-injectable

Country Status (19)

Country	Link
US (2)	US9907739B2 (fr)
EP (1)	EP2912074B2 (fr)
JP (1)	JP6521862B2 (fr)
KR (1)	KR102178252B1 (fr)
AU (1)	AU2013336274B2 (fr)
BR (1)	BR112015009162B1 (fr)
CA (1)	CA2888616C (fr)
DK (1)	DK2912074T4 (fr)
ES (1)	ES2735017T5 (fr)
FR (1)	FR2997014B1 (fr)
HR (1)	HRP20191196T1 (fr)
HU (1)	HUE044362T2 (fr)
PL (1)	PL2912074T5 (fr)
PT (1)	PT2912074T (fr)
RS (1)	RS59079B1 (fr)
RU (1)	RU2653729C2 (fr)
SI (1)	SI2912074T1 (fr)
TR (1)	TR201911149T4 (fr)
WO (1)	WO2014064632A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6906885B2 (ja)	2014-11-14	2021-07-21	ロレアル	しわを減少させるためのマイクロニードルシート
FR3034195B1 (fr) *	2015-03-24	2017-04-21	Teoxane	Procede d'evaluation des performances mecaniques d'un gel de comblement
CN109890428B (zh) *	2016-10-13	2022-06-10	阿勒根公司	用于真皮填充剂应用的凝聚层透明质素水凝胶
EP3562470A1 (fr)	2016-12-29	2019-11-06	Nestlé Skin Health SA	Composition comprenant un acide hyaluronique (ah) réticulé en combinaison avec un ah de faible poids moléculaire et/ou un agent stimulant la synthèse d'ah endogène
EP3562468A1 (fr) *	2016-12-29	2019-11-06	Nestlé Skin Health SA	Vésicules multilamellaires micro- ou nanoparticulaires, compositions les comprenant et leur procédé d'utilisation dans les soins de la peau
WO2018122343A1 (fr) *	2016-12-29	2018-07-05	Nestlé Skin Health Sa	Vésicules micro- ou nanoparticulaires comprenant de l'acide hyaluronique réticulé, compositions les comprenant et leur méthode d'utilisation dans les soins de la peau
KR20200121828A (ko) *	2018-02-16	2020-10-26	도요보 가부시키가이샤	안티폴루션제 및 피부외용 조성물
KR20210021363A (ko)	2018-06-15	2021-02-25	크로마-파르마 게엠베하	안정화된 히알루론산
JP7160954B2 (ja)	2018-06-29	2022-10-25	ザプロクターアンドギャンブルカンパニー	二相製品
KR20210008853A (ko)	2018-06-29	2021-01-25	더 프록터 앤드 갬블 캄파니	이중상 제품 분배기
JP7208267B2 (ja)	2018-06-29	2023-01-18	ザプロクターアンドギャンブルカンパニー	二相製品
EP3813768A2 (fr)	2018-06-29	2021-05-05	The Procter & Gamble Company	Produits à deux phases
AU2019299812B2 (en) *	2018-07-06	2022-09-29	Lg Chem, Ltd.	Hyaluronic acid filler having high viscoelasticity and high cohesiveness
CA3106381C (fr) *	2018-07-10	2024-02-13	Lg Chem, Ltd.	Produit de comblement a base d'acide hyaluronique presentant une capacite de comblement elevee et ne necessitant qu'une faible force d'injection
KR102566287B1 (ko) *	2018-11-30	2023-08-11	주식회사 엘지화학	히알루론산을 포함하는 활액보충재용 조성물
KR102334794B1 (ko) *	2018-12-20	2021-12-03	주식회사 엘지화학	우수한 필러 특성을 갖는 히알루론산 하이드로겔을 포함하는 필러
JP1665824S (fr)	2019-08-21	2020-08-11
EP4021392A1 (fr) *	2019-08-30	2022-07-06	The Procter & Gamble Company	Composition de soin capillaire conditionnée
CN116322607A (zh)	2020-10-27	2023-06-23	宝洁公司	加温调理剂
USD1006632S1 (en)	2020-12-11	2023-12-05	The Procter & Gamble Company	Container for hair care products
USD1012718S1 (en)	2020-12-21	2024-01-30	The Procter & Gamble Company	Container for hair care product
EP4319819A4 (fr) *	2021-04-09	2025-02-26	Colorado School Of Mines	Gels zwitterioniques réticulés par voie radicalaire et leurs utilisations
CN113896915B (zh) *	2021-11-10	2024-02-13	爱美客技术发展股份有限公司	一种凝胶材料及其制备方法与应用
WO2023082084A1 (fr) *	2021-11-10	2023-05-19	爱美客技术发展股份有限公司	Matériau sous forme de gel, son procédé de préparation, et son utilisation
CN116173293A (zh)	2021-11-29	2023-05-30	爱美客技术发展股份有限公司	一种复合凝胶、制备方法及应用
EP4448588A1 (fr)	2022-01-11	2024-10-23	WiQo S.p.A.	Nouveaux dérivés d'acides hyaluroniques en tant que combleurs innovants
WO2023221082A1 (fr) *	2022-05-20	2023-11-23	爱美客技术发展股份有限公司	Matériau polymère greffé, procédé de préparation associé et son application
WO2024040480A1 (fr) *	2022-08-24	2024-02-29	爱美客技术发展股份有限公司	Matériau de gel et son procédé de préparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2752843B1 (fr) *	1996-08-30	1998-10-16	Sod Conseils Rech Applic	Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303735B1 (it)	1998-11-11	2001-02-23	Falorni Italia Farmaceutici S	Acidi ialuronici reticolati e loro usi medici.
KR100375299B1 (ko)	2000-10-10	2003-03-10	주식회사 엘지생명과학	히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US20040162235A1 (en) *	2003-02-18	2004-08-19	Trubetskoy Vladimir S.	Delivery of siRNA to cells using polyampholytes
US8524213B2 (en)	2003-12-30	2013-09-03	Genzyme Corporation	Polymeric materials, their preparation and use
NO20044818D0 (no)	2004-11-05	2004-11-05	Bioforsk As	Spermin i kosmetiske preparater
US20060105022A1 (en)	2004-11-15	2006-05-18	Shiseido Co., Ltd.	Process for preparing crosslinked hyaluronic acid gel
CN101107270B (zh)	2004-11-24	2011-11-23	诺维信生物制药丹麦公司	用二乙烯基砜交联透明质酸的方法
EP1884231A1 (fr)	2006-08-01	2008-02-06	Auriga International S.A.	Composition cosmétique ou pharmaceutique contenant acide hyaluronique
FR2908415B1 (fr)	2006-11-10	2009-01-23	Abr Dev Sarl	Acide hyaluronique reticule et son procede de preparation
WO2010049562A1 (fr)	2008-10-28	2010-05-06	Universidade De Santiago De Compostela	Systèmes nanoparticulaires élaborés à base de polymères anioniques
FR2945293B1 (fr) *	2009-05-11	2011-06-17	Teoxane	Procede de preparation d'un gel reticule.
ES2368307B1 (es) *	2010-04-28	2012-10-17	Universidade De Santiago De Compostela	Hidrogeles elaborados a base de polímeros aniónicos de origen natural.
WO2012008722A2 (fr) *	2010-07-12	2012-01-19	신풍제약 주식회사	Composition de charge pour le renforcement de tissus

2012
- 2012-10-24 FR FR1260146A patent/FR2997014B1/fr active Active
2013
- 2013-10-24 TR TR2019/11149T patent/TR201911149T4/tr unknown
- 2013-10-24 AU AU2013336274A patent/AU2013336274B2/en active Active
- 2013-10-24 DK DK13820892.1T patent/DK2912074T4/da active
- 2013-10-24 PL PL13820892T patent/PL2912074T5/pl unknown
- 2013-10-24 JP JP2015538611A patent/JP6521862B2/ja active Active
- 2013-10-24 WO PCT/IB2013/059607 patent/WO2014064632A1/fr active Application Filing
- 2013-10-24 BR BR112015009162-8A patent/BR112015009162B1/pt active IP Right Grant
- 2013-10-24 HU HUE13820892 patent/HUE044362T2/hu unknown
- 2013-10-24 CA CA2888616A patent/CA2888616C/fr active Active
- 2013-10-24 RU RU2015118969A patent/RU2653729C2/ru active
- 2013-10-24 KR KR1020157013662A patent/KR102178252B1/ko active Active
- 2013-10-24 US US14/437,917 patent/US9907739B2/en active Active
- 2013-10-24 ES ES13820892T patent/ES2735017T5/es active Active
- 2013-10-24 SI SI201331513T patent/SI2912074T1/sl unknown
- 2013-10-24 PT PT13820892T patent/PT2912074T/pt unknown
- 2013-10-24 EP EP13820892.1A patent/EP2912074B2/fr active Active
- 2013-10-24 RS RS20190862A patent/RS59079B1/sr unknown
2018
- 2018-01-18 US US15/874,144 patent/US10307362B2/en active Active
2019
- 2019-07-01 HR HRP20191196TT patent/HRP20191196T1/hr unknown

Also Published As

Publication number	Publication date
US20150272851A1 (en)	2015-10-01
AU2013336274B2 (en)	2017-08-24
RU2015118969A (ru)	2016-12-20
WO2014064632A1 (fr)	2014-05-01
BR112015009162B1 (pt)	2021-10-13
AU2013336274A1 (en)	2015-05-07
HRP20191196T1 (hr)	2019-10-18
ES2735017T3 (es)	2019-12-13
PL2912074T5 (pl)	2022-04-04
DK2912074T3 (da)	2019-07-22
EP2912074B2 (fr)	2021-12-22
SI2912074T1 (sl)	2019-08-30
PT2912074T (pt)	2019-07-19
JP6521862B2 (ja)	2019-05-29
RU2653729C2 (ru)	2018-05-14
ES2735017T5 (es)	2022-04-28
US10307362B2 (en)	2019-06-04
US9907739B2 (en)	2018-03-06
HUE044362T2 (hu)	2019-10-28
PL2912074T3 (pl)	2019-09-30
RS59079B1 (sr)	2019-09-30
TR201911149T4 (tr)	2019-08-21
DK2912074T4 (da)	2022-03-14
FR2997014A1 (fr)	2014-04-25
KR20150079786A (ko)	2015-07-08
EP2912074A1 (fr)	2015-09-02
CA2888616C (fr)	2020-09-15
BR112015009162A2 (pt)	2017-10-03
US20180140530A1 (en)	2018-05-24
EP2912074B1 (fr)	2019-05-01
CA2888616A1 (fr)	2014-05-01
JP2016507592A (ja)	2016-03-10
KR102178252B1 (ko)	2020-11-13

Publication	Publication Date	Title
FR2997014B1 (fr)	2015-03-20	Composition sterile dermo-injectable
DK3679922T3 (da)	2021-10-18	Sprøjte
DK3685826T3 (da)	2022-02-14	Sprøjte
PT3725778T (pt)	2021-09-22	Formulações de enzalutamida
DK2825087T3 (da)	2019-05-13	Otoscanner
DK2839013T3 (da)	2020-09-14	Ikke-disruptiv-gen-targetering
BR112014032798A2 (pt)	2017-06-27	composição
DE112012006109A5 (de)	2014-12-18	Okklusionsschienenanordnung
ME03413B (fr)	2020-01-20	Compositions
EP2934132A4 (fr)	2016-08-17	Désinfectant
DK2825157T3 (da)	2019-01-02	Aminosyrelipider
EP2812047A4 (fr)	2015-10-21	Système d'accès via une occlusion
DK2897594T3 (da)	2020-06-29	Farmaceutisk sammensætning
EP2920370A4 (fr)	2016-08-03	Montant
DK2831122T3 (da)	2016-05-17	Anthocyanidin-kompleks
DE112012006214T8 (de)	2015-04-16	Wulstringwickler
EP2913076A4 (fr)	2016-08-17	Seringue
HK1204947A1 (zh)	2015-12-11	滅菌組合物
EP2931176A4 (fr)	2016-10-26	Fronde médicale
BR112014032712A2 (pt)	2017-06-27	composição
HUE049445T2 (hu)	2020-09-28	Új kompozíciók
DE112012005566T8 (de)	2014-11-13	Seltenerdnanoverbundmagnet
EP2837670A4 (fr)	2016-01-13	Composition contenant un fluorobiphényle
DK2811828T3 (da)	2021-11-15	Adjuvanssammensætninger
DE102013212400A8 (de)	2014-08-21	Abdeckplattenstützbaugruppe

Legal Events

Date	Code	Title	Description
2016-08-31	PLFP	Fee payment	Year of fee payment: 5
2017-08-30	PLFP	Fee payment	Year of fee payment: 6
2018-08-30	PLFP	Fee payment	Year of fee payment: 7
2019-09-30	PLFP	Fee payment	Year of fee payment: 8
2020-08-26	PLFP	Fee payment	Year of fee payment: 9
2021-08-24	PLFP	Fee payment	Year of fee payment: 10
2022-09-28	PLFP	Fee payment	Year of fee payment: 11
2023-08-24	PLFP	Fee payment	Year of fee payment: 12
2024-10-21	PLFP	Fee payment	Year of fee payment: 13